M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. (1st February 2022)
- Record Type:
- Journal Article
- Title:
- M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. (1st February 2022)
- Main Title:
- M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942
- Authors:
- Wei, Ke
Ma, Zijian
Yang, Fengming
Zhao, Xin
Jiang, Wei
Pan, Chunfeng
Li, Zhihua
Pan, Xianglong
He, Zhicheng
Xu, Jing
Wu, Weibing
Xia, Yang
Chen, Liang - Abstract:
- Abstract: Tumor-associated macrophages (TAMs) are the major components of the tumor microenvironment that contribute to metastasis in lung adenocarcinoma (LUAD). The potential of TAM-derived exosomes for biomarker discovery in tumor initiation and progression has been recently reported. However, studies on macrophage-derived exosomes in LUAD remain limited. We investigated the role of M2 macrophage-derived exosomes in LUAD both in vivo and in vitro and its underlying mechanism. We showed that the infiltration of M2 macrophages was positively correlated with LUAD metastasis. M2 macrophage-derived exosomes could be taken up by LUAD cells to promote cell migration, invasion, and angiogenesis. Furthermore, miR-942 could be packaged into exosomes secreted by M2 macrophages. Mechanistically, exosomal miR-942 regulates FOXO1 protein expression by binding to the 3′-UTR region of FOXO1 and further alleviates β-catenin inhibition in LUAD cells. Collectively, we demonstrated that M2 macrophage-derived miRNA-containing exosomes promote LUAD cell invasion and migration and facilitate angiogenesis, thereby providing a new therapeutic target for metastatic LUAD. Highlights: Metastatic lung adenocarcinoma tissues had high M2 macrophage infiltration. M2 macrophage-derived exosomal miR-942 promoted lung tumor metastasis in vivo. M2 macrophage-derived exosomal miR-942 induced angiogenesis in vivo. miR-942 regulates FOXO1 expression to activate the Wnt/β-catenin pathway.
- Is Part Of:
- Cancer letters. Volume 526(2022)
- Journal:
- Cancer letters
- Issue:
- Volume 526(2022)
- Issue Display:
- Volume 526, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 526
- Issue:
- 2022
- Issue Sort Value:
- 2022-0526-2022-0000
- Page Start:
- 205
- Page End:
- 216
- Publication Date:
- 2022-02-01
- Subjects:
- TAMs -- miRNA -- FOXO1 -- Metastasis -- Angiogenesis
CM conditioned medium -- GEPIA gene expression profiling analysis -- LUAD lung adenocarcinoma -- miRNAs microRNAs -- NSCLC non-small cell lung cancer -- TAMs tumor-associated macrophages -- TCIA The Cancer Immunome Atlas -- TME tumor microenvironment
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2021.10.045 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20268.xml